US Stock MarketDetailed Quotes

RGBPP REGEN BIOPHARMA INC

Watchlist
  • 0.150
  • +0.030+25.00%
15min DelayTrading Sep 16 11:59 ET
0Market Cap0.00P/E (TTM)

REGEN BIOPHARMA INC Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-98.36%-172.59K
-294.64%-209.32K
-1,451.39%-162.34K
71.34%-173.92K
72.56%-23.41K
43.42%-87.01K
40.22%-53.04K
96.25%-10.46K
46.33%-606.92K
92.01%-85.29K
Net income from continuing operations
-31.15%-130.12K
-122.77%-122.47K
-121.38%-349.76K
-52.67%1.16M
-316.56%-325.03K
-100.15%-99.22K
99.92%-54.98K
-38.16%1.64M
136.12%2.44M
94.36%-78.03K
Operating gains losses
----
----
----
----
----
----
--0
---1.15K
-99.65%1.83K
----
Other non cash items
477.30%4.34K
--4.34K
436,700.00%4.37K
114.22%249.72K
402.37%250.86K
-102.20%-1.15K
--0
-100.00%1
106.39%116.57K
344.62%49.94K
Change In working capital
-502.39%-49.13K
-4,807.59%-91.19K
98.91%-21.79K
38.53%-1.93M
185.99%50.76K
100.02%12.21K
-100.00%1.94K
35.08%-1.99M
-149.80%-3.14M
80.55%-59.03K
-Change in receivables
-221.48%-27.43K
-152.16%-27.43K
-110.03%-12.3K
817.15%254.27K
19.76%56.55K
181.92%22.58K
290.79%52.58K
544.76%122.58K
69.34%-35.46K
269.48%47.22K
-Change in prepaid assets
-163.26%-7.5K
-89.24%200
-57.83%5K
21.79%20.95K
-47.04%-4.62K
77.19%11.86K
-72.66%1.86K
72.93%11.86K
135.72%17.2K
93.47%-3.14K
-Change in payables and accrued expense
82.31%17.17K
-314.15%-32.32K
64.67%32.27K
26.39%59.46K
-50.09%15.35K
-46.37%9.42K
-70.92%15.09K
136.86%19.6K
-86.59%47.04K
-64.12%30.75K
-Change in other current liabilities
--261
----
----
29.23%-2.15M
--0
--0
-100.05%-35.95K
28.64%-2.12M
-171.29%-3.04M
63.65%-102.21K
-Change in other working capital
0.00%-31.64K
0.00%-31.64K
-47.81%-46.77K
11.22%-111.43K
47.81%-16.51K
-1.11%-31.64K
-2.25%-31.64K
0.00%-31.64K
-106.79%-125.52K
1.09%-31.64K
Cash from discontinued investing activities
Operating cash flow
-98.36%-172.59K
-294.64%-209.32K
-1,451.52%-162.34K
71.34%-173.92K
72.56%-23.41K
29.65%-87.01K
55.36%-53.04K
96.25%-10.46K
46.33%-606.92K
92.01%-85.29K
Investing cash flow
Cash flow from continuing investing activities
-94.95%25K
Net investment purchase and sale
----
----
----
----
----
----
----
----
-94.95%25K
----
Cash from discontinued investing activities
Investing cash flow
----
----
----
----
----
----
----
----
-94.95%25K
----
Financing cash flow
Cash flow from continuing financing activities
156.32K
62.94%162.94K
165.8K
359.21%243.75K
28,707.62%143.75K
0
100K
0
-106.90%-94.04K
-99.96%499
Net issuance payments of debt
--21K
-125.00%-25K
---46.5K
359.21%243.75K
28,707.62%143.75K
--0
--100K
--0
-106.90%-94.04K
-99.96%499
Net common stock issuance
--135.33K
--187.94K
--212.3K
----
----
----
----
--0
----
----
Cash from discontinued financing activities
Financing cash flow
--156.32K
62.94%162.94K
--165.8K
359.21%243.75K
28,707.62%143.75K
--0
--100K
--0
-106.90%-94.04K
-99.96%499
Net cash flow
Beginning cash position
-10.93%78.11K
205.58%124.5K
136.38%121.04K
-92.96%51.2K
-99.38%692
-62.63%87.7K
-88.47%40.74K
-92.96%51.2K
--727.16K
-41.02%110.99K
Current changes in cash
81.31%-16.27K
-198.77%-46.38K
133.07%3.46K
110.33%69.83K
301.28%120.35K
29.65%-87.01K
139.52%46.96K
97.20%-10.46K
-192.96%-675.96K
-111.09%-59.79K
End cash Position
8,837.72%61.85K
-10.93%78.11K
205.58%124.5K
136.38%121.04K
136.38%121.04K
-99.38%692
-62.63%87.7K
-88.47%40.74K
-92.96%51.2K
-92.96%51.2K
Free cash flow
-98.36%-172.59K
-294.64%-209.32K
-1,451.52%-162.34K
71.34%-173.92K
72.56%-23.41K
29.65%-87.01K
55.36%-53.04K
96.25%-10.46K
46.33%-606.92K
92.01%-85.29K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -98.36%-172.59K-294.64%-209.32K-1,451.39%-162.34K71.34%-173.92K72.56%-23.41K43.42%-87.01K40.22%-53.04K96.25%-10.46K46.33%-606.92K92.01%-85.29K
Net income from continuing operations -31.15%-130.12K-122.77%-122.47K-121.38%-349.76K-52.67%1.16M-316.56%-325.03K-100.15%-99.22K99.92%-54.98K-38.16%1.64M136.12%2.44M94.36%-78.03K
Operating gains losses --------------------------0---1.15K-99.65%1.83K----
Other non cash items 477.30%4.34K--4.34K436,700.00%4.37K114.22%249.72K402.37%250.86K-102.20%-1.15K--0-100.00%1106.39%116.57K344.62%49.94K
Change In working capital -502.39%-49.13K-4,807.59%-91.19K98.91%-21.79K38.53%-1.93M185.99%50.76K100.02%12.21K-100.00%1.94K35.08%-1.99M-149.80%-3.14M80.55%-59.03K
-Change in receivables -221.48%-27.43K-152.16%-27.43K-110.03%-12.3K817.15%254.27K19.76%56.55K181.92%22.58K290.79%52.58K544.76%122.58K69.34%-35.46K269.48%47.22K
-Change in prepaid assets -163.26%-7.5K-89.24%200-57.83%5K21.79%20.95K-47.04%-4.62K77.19%11.86K-72.66%1.86K72.93%11.86K135.72%17.2K93.47%-3.14K
-Change in payables and accrued expense 82.31%17.17K-314.15%-32.32K64.67%32.27K26.39%59.46K-50.09%15.35K-46.37%9.42K-70.92%15.09K136.86%19.6K-86.59%47.04K-64.12%30.75K
-Change in other current liabilities --261--------29.23%-2.15M--0--0-100.05%-35.95K28.64%-2.12M-171.29%-3.04M63.65%-102.21K
-Change in other working capital 0.00%-31.64K0.00%-31.64K-47.81%-46.77K11.22%-111.43K47.81%-16.51K-1.11%-31.64K-2.25%-31.64K0.00%-31.64K-106.79%-125.52K1.09%-31.64K
Cash from discontinued investing activities
Operating cash flow -98.36%-172.59K-294.64%-209.32K-1,451.52%-162.34K71.34%-173.92K72.56%-23.41K29.65%-87.01K55.36%-53.04K96.25%-10.46K46.33%-606.92K92.01%-85.29K
Investing cash flow
Cash flow from continuing investing activities -94.95%25K
Net investment purchase and sale ---------------------------------94.95%25K----
Cash from discontinued investing activities
Investing cash flow ---------------------------------94.95%25K----
Financing cash flow
Cash flow from continuing financing activities 156.32K62.94%162.94K165.8K359.21%243.75K28,707.62%143.75K0100K0-106.90%-94.04K-99.96%499
Net issuance payments of debt --21K-125.00%-25K---46.5K359.21%243.75K28,707.62%143.75K--0--100K--0-106.90%-94.04K-99.96%499
Net common stock issuance --135.33K--187.94K--212.3K------------------0--------
Cash from discontinued financing activities
Financing cash flow --156.32K62.94%162.94K--165.8K359.21%243.75K28,707.62%143.75K--0--100K--0-106.90%-94.04K-99.96%499
Net cash flow
Beginning cash position -10.93%78.11K205.58%124.5K136.38%121.04K-92.96%51.2K-99.38%692-62.63%87.7K-88.47%40.74K-92.96%51.2K--727.16K-41.02%110.99K
Current changes in cash 81.31%-16.27K-198.77%-46.38K133.07%3.46K110.33%69.83K301.28%120.35K29.65%-87.01K139.52%46.96K97.20%-10.46K-192.96%-675.96K-111.09%-59.79K
End cash Position 8,837.72%61.85K-10.93%78.11K205.58%124.5K136.38%121.04K136.38%121.04K-99.38%692-62.63%87.7K-88.47%40.74K-92.96%51.2K-92.96%51.2K
Free cash flow -98.36%-172.59K-294.64%-209.32K-1,451.52%-162.34K71.34%-173.92K72.56%-23.41K29.65%-87.01K55.36%-53.04K96.25%-10.46K46.33%-606.92K92.01%-85.29K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data